
Optimal timing for non-culprit lesion revascularization in ACS remains debated. The meta-analysis of 10 randomized controlled trials (n=3886) found no difference in 1-year mortality between immediate and staged revascularization. However, immediate revascularization significantly reduced the risk of target vessel revascularization (RR 0.64, p=0.03) and myocardial infarction (RR 0.57, p=0.01). These findings support immediate revascularization for improved outcomes in multivessel coronary artery disease.
Like
Save
Share